Assessment of Cognitive Decline in Old Age with Brief Tests Amenable to Telephone AdministrationWilson R.S.a-c · Bennett D.A.a, b
aRush Alzheimer’s Disease Center and Departments of bNeurological Sciences and cPsychology, Rush University Medical Center, Chicago, Ill., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The adequacy with which brief cognitive tests suitable for telephone administration can assess cognitive decline due to aging and Alzheimer’s disease is uncertain. The authors examined these issues with data from the Religious Orders Study, which involves annual clinical evaluations and brain donation at death. Participants are 996 older Catholic clergy members. Analyses focused on seven cognitive tests which can be administered in person or by telephone in less than 15 min. Composite measures of global cognition and of episodic, semantic and working memory were formed. During a mean of 5.8 years of follow-up, performance on each composite measure declined in persons with and without dementia at baseline. Among those without dementia, possession of the apolipoprotein E ε4 allele was associated with more rapid cognitive decline, especially in episodic and working memory. Level of performance on each cognitive measure proximate to death was inversely related to the level of cortical plaques and tangles in the brain. In a subset of persons who were given the tests by telephone, there was no evidence that performance differed from in-person administration. The results suggest that briefly assessing cognition with tests amenable to telephone administration may prove useful in longitudinal epidemiologic studies of older persons.
© 2005 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.